Module

Cardiovascular Risk in HIV: Disease- and Treatment-Related Mechanisms in the HAART ERA

Source: Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

Cardiovascular Risk in HIV: Disease- and Treatment-Related Mechanisms in the HAART ERA


Faculty:

Peter Reiss, MD, PhD
  • Peter Reiss, MD, PhD

CME CREDIT INFORMATION

Release Date: 12/13/06

Expiration Date: 12/12/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.2 Nursing CE credits

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the epidemiology of dyslipidemia and other cardiovascular risk factors in HIV-infected patients
  • Review the association between specific antiretroviral agents and cardiovascular risk factors
  • Describe the significance of traditional cardiovascular risk factors in HIV-infected patients

Topics covered include:

  • Introduction
  • Lipid Changes Associated With HIV Infection
  • Lipodystrophy Associated With HIV Infection
  • Effects of Antiretroviral Drugs on Lipid Metabolism
  • Mechanisms of HAART-Induced Lipid Changes and Glucose Abnormalities
  • CV Disease Associated With HIV Infection
  • Effect of HAART on CV Disease
  • Surrogate Measures of CV Risk
  • Conclusion
  • Summary and Implications for Clinical Practice
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.